InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Kanner Steven, Directeur Scientifique. Insider active across 1 company, notably Caribou Biosciences, Inc.. Aggregated, 4 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €312k. History available since 12 October 2021. The latest transaction was filed on 13 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations4 total
68,306 shares@ US$1.810.056% mcap26.2% of flowCommon StockSEC:0001209191-22-029893:0
9,171 shares@ US$2.690.011% mcap4.9% of flowCommon StockSEC:0001209191-22-016872:0
99,548 shares@ US$1.81100.0% of flowCommon StockSEC:0001209191-21-060424
Ideal exit: 9 Jul 2022 (T+270)
99,548 shares@ US$1.810.074% mcap34.4% of flowCommon StockSEC:0001209191-21-060424:0
Ideal exit: 9 Jul 2022 (T+270)
4 of 4 declarations
About Kanner Steven
Steven Kanner is the Chief Scientific Officer at Caribou Biosciences, Inc. In this role, he is responsible for leading research and development initiatives, focusing on innovation in the biotechnology sector. Kanner plays a key role in formulating scientific strategies and managing research projects, thereby contributing to the advancement of the company's technologies.
